ASP ISOTOPES INC - Form 8-K current report business updates

Form 8-K current report – business updates

ASP ISOTOPES INC.
(Incorporated in the State of Delaware,
United States of America)
(Delaware file number 6228898)
Ticker Symbol: NASDAQ: ASPI
ISIN: US00218A1051
LEI: 6488WHV94BZ496OZ3219
JSE Share Code: ISO
("ASPI" or "the Company")


FORM 8-K CURRENT REPORT – BUSINESS UPDATES


Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, ASPI stockholders are advised
that a Form 8-K has been filed with the U.S. Securities and Exchange Commission.

On October 13, 2025, the Company issued a press release announcing business updates, including a
supply agreement for enriched silicon-28 and an acquisition of a radiopharmacy in the United States. A
copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated
by reference, other than the seventh, tenth and eleventh paragraphs of the press release.

A copy of the Form 8-K can be found at:
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001921865/000147793225007513/aspi_8k.htm


14 October 2025

Sponsor
Valeo Capital Proprietary Limited

Date: 14-10-2025 01:28:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.